Previous Page  9 / 27 Next Page
Information
Show Menu
Previous Page 9 / 27 Next Page
Page Background

Page 54

conferenceseries

.com

Volume 7, Issue 7 (Suppl)

J Gastrointest Dig Syst

ISSN: 2161-069X JGDS, an open access journal

Gastroenterologists 2017

December 14-15, 2017

December 14-15, 2017 Dubai, UAE

11

th

World

Gastroenterologists Summit

Pediatric GI motility: Clinical updates

Anil Darbari

Children’s National Health System, USA

T

he field of pediatric GI motility has seen several advances over the recent past. Updates in Pathophysiology: As the field

of neuro-gastroenterology has advanced, knowledge about the pathophysiology at the cellular, tissue, organ and torso

levels has all advanced. While the Enteric Nervous System (ENS) has been studied for decades, advances allow us better

understanding of the intrinsic primary afferent neurons (IPANs), interneurons, motor neurons and the intestinofugal neurons.

There is better understanding of the interstitial cells of Cajal (ICC) as well as the extrinsic control of the ENS and of the

sensation of the gut. Updates in GI motility studies: Various modalities for assessing GI motility have been utilized. From

radiological testing of scintigraphy, radiopaque markers and contrast studies, there have been advances with the use of MRI

and fMRI studies to evaluate how intestines move. Gastroenterologists have also paid much attention to this field in the 21

st

century. The use of manometry has advanced tremendously with the advent of high-resolution manometry (HRM), high

resolution impedance manometry (HRIM) and 3D HRM. Sleeve Manometry and EndoFLIP have changed our understanding

of reflux parameters. With the advent of the wireless capsule, transit times and other motility parameters can be studied non-

invasively. Updates in therapies for GI motility disorders: Newer drugs continue to advance the field of neuro-gastrointestinal

pharmacological therapy. Endoscopic therapy has shown tremendous progress with procedures such as endoscopic dilatation,

injection of botulinum toxin to the various sphincters and the advent of endoscopic procedures such as Per Oral Endoscopic

Myotomy (POEM). Surgical therapy techniques continue to be refined progressively and used for primary surgical procedures

such as minimally invasive surgery (MIS), laparoscopy and surgical resections. New therapeutic techniques such as gastric

electric stimulation (GES), sacral nerve stimulators as well as the prospect of stem cell transplant continue to keep the horizon

of GI motility disorders bright.

ADarbari@childrensnational.org

J Gastrointest Dig Syst 2017, 7:7 (Suppl)

DOI: 10.4172/2161-069X-C1-062